We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Almac Group Addresses Industry Demand For Multiparticulate Drug Products

News   Oct 12, 2015

 
Almac Group Addresses Industry Demand For Multiparticulate Drug Products
 
 
 

RELATED ARTICLES

Kicking the Habit: Effectiveness of Different Forms of Nicotine Replacement Therapy

News

New evidence published in the Cochrane Library provides high quality evidence that people who use a combination of nicotine replacement therapies (a patch plus a short acting form, such as gum or lozenge) are more likely to successfully quit smoking than people who use a single form of the medicine.

READ MORE

New Version of CAR T-Cell Therapy Eliminates Severe Side Effects

News

An advance in the breakthrough cancer treatment known as CAR T-cell therapy appears to eliminate its severe side effects, making the treatment safer and potentially available in outpatient settings, a new USC study shows.

READ MORE

Insights on Marijuana and Opioid Use in People With Cancer

News

A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE